In addition, we also examined the mutational status of BRCA1/2 of OV cells and half‐maximal growth‐inhibitory concentration (IC50) data of PARPi (Olaparib, Niraparib, and Talazoparib) downloaded from the Genomics of Drug Sensitivity in Cancer dataset (GDSC, https://www.cancerrxgene.org/). This evidence concerns the gene BRCA1 and cancer.